Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)

NCT07457424 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Disease
Obesity & Overweight

Interventions

DRUG: semaglutide 1 mg weekly injection

Sponsor

University College Dublin

Collaborators

[object Object]